A cross-sectional study of agreement between the Hospital Anxiety and Depression Scale and patient- and radiation oncologist–reported single-item assessment of depression and anxiety
Corresponding Author
Lisa Mackenzie
Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia
Hunter Medical Research Institute, Newcastle, NSW, Australia
Graduate School of Medicine, Kyoto University, Kyoto, Japan
Correspondence
Lisa Mackenzie, Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
Email: [email protected]
Search for more papers by this authorMariko Carey
Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia
Hunter Medical Research Institute, Newcastle, NSW, Australia
Search for more papers by this authorEiji Suzuki
Breast Surgery, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorMichio Yoshimura
Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorMasakazu Toi
Breast Surgery, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorCatherine D'Este
National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT, Australia
Search for more papers by this authorRob Sanson-Fisher
Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia
Hunter Medical Research Institute, Newcastle, NSW, Australia
Search for more papers by this authorCorresponding Author
Lisa Mackenzie
Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia
Hunter Medical Research Institute, Newcastle, NSW, Australia
Graduate School of Medicine, Kyoto University, Kyoto, Japan
Correspondence
Lisa Mackenzie, Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
Email: [email protected]
Search for more papers by this authorMariko Carey
Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia
Hunter Medical Research Institute, Newcastle, NSW, Australia
Search for more papers by this authorEiji Suzuki
Breast Surgery, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorMichio Yoshimura
Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorMasakazu Toi
Breast Surgery, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorCatherine D'Este
National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT, Australia
Search for more papers by this authorRob Sanson-Fisher
Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia
Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia
Hunter Medical Research Institute, Newcastle, NSW, Australia
Search for more papers by this authorAbstract
Objective
To describe among radiation oncology patients: (1) the proportion likely to be experiencing symptoms of depression and anxiety as identified by (a) the Hospital Anxiety and Depression Scale (HADS; standardised tool), (b) patient-reported single items (ultrashort tool), and (c) radiation oncologist–reported single items (clinician judgement); (2) preferences for being offered psychological support; and (3) agreement between single-item measures and the HADS.
Methods
Adult cancer patients (n = 152; consent rate 58%) receiving radiotherapy completed a touchscreen tablet survey assessing symptoms of anxiety and depression (HADS and a single-item tool) and support preferences. Each participant's treating radiation oncologist completed a survey assessing his or her perception of whether the patient was anxious or depressed.
Results
Prevalence estimates for likely depression (6.9-18%) and anxiety (17-33%) overlapped across the 3 measures. Overall, only 9.9% of patients (95% CI, 5.6%-16%) wanted to be offered psychological support. For depression, agreement between the HADS and ultrashort tool was fair (κ = 0.37, P < 0.0001); agreement between the HADS and clinician judgement was slight (κ = 0.14, P < 0.05). For anxiety, agreement between the HADS and clinician judgement was not significantly greater than chance alone (κ = 0.04, P = 0.33), and agreement between the HADS and ultrashort tool was moderate (κ = 0.49, P < 0.0001).
Conclusions
These findings highlight the important role that oncology consultations play in interpreting assessment tool results and responding to individual patient's history and preferences for psychological support.
CONFLICT OF INTEREST
All authors declare that they have no competing interests.
Supporting Information
| Filename | Description |
|---|---|
| pon_4736-sup-001-suppl_data.zipapplication/x-zip-compressed, 63 KB |
Table S1: Agreement between HADS-D and patient-perceived depression (n, row %) Table S2: Agreement between HADS-D and clinician judgement of patients' depression (n, row %) Table S3: Agreement between HADS-A and patient-perceived anxiety (n, row %) Table S4: Agreement between HADS-A and clinician judgement of patients' anxiety (n, row %) Text S1: Sample size Text S2: Reasons for ineligibility |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Nakash O, Levav I, Aguilar-Gaxiola S, et al. Comorbidity of common mental disorders with cancer and their treatment gap: findings from the World Mental Health Surveys. Psychooncology. 2014; 23(1): 40-51.
- 2Mitchell AJ. Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol. 2013; 52(2): 216-224.
- 3Butow P, Price MA, Shaw JM, et al. Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines. Psychooncology. 2015; 24(9): 987-1001.
- 4Pirl WF, Fann JR, Greer JA, et al. Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer. 2014; 120(19): 2946-2954.
- 5Lazenby M, Tan H, Pasacreta N, Ercolano E, McCorkle R. The five steps of comprehensive psychosocial distress screening. Curr Oncol Rep. 2015; 17: 447.
- 6Akechi T, Okuyama T, Sugawara Y, Shima Y, Furukawa TA, Uchitomi Y. Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage. 2006; 31(1): 5-12.
- 7Akizuki N, Akechi T, Nakanishi T, et al. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer. 2003; 97(10): 2605-2613.
- 8Okuyama T, Kizawa Y, Morita T, et al. Current status of distress screening in designated cancer hospitals: a cross-sectional nationwide survey in Japan. J Natl Compr Canc Netw. 2016; 14(9): 1098-1104.
- 9Luckett T, Butow PN, King MT, et al. A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer. 2010; 18(10): 1241-1262.
- 10Mitchell AJ, Meader N, Symonds P. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord. 2010; 126(3): 335-348.
- 11Carey M, Noble N, Sanson-Fisher R, Mackenzie L. Identifying psychological morbidity among people with cancer using the Hospital Anxiety and Depression Scale: time to revisit first principles? Psychooncology. 2012; 21(3): 229-238.
- 12Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009; 101(21): 1464-1488.
- 13Okuyama T, Akechi T, Yamashita H, et al. Oncologists' recognition of supportive care needs and symptoms of their patients in a breast cancer outpatient consultation. Jpn J Clin Oncol. 2011; 41(11): 1251-1258.
- 14Jorm AF, Nakane Y, Christensen H, Yoshioka K, Griffiths KM, Wata Y. Public beliefs about treatment and outcome of mental disorders: a comparison of Australia and Japan. BMC Med. 2005; 3(1): 12.
- 15Passik SD, Dugan W, McDonald MV, et al. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1998; 16(4): 1594-1600.
- 16Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001; 84(8): 1011-1015.
- 17Mitchell AJ, Baker-Glenn EA, Granger L, Symonds P. Can the distress thermometer be improved by additional mood domains? Part I. Initial validation of the Emotion Thermometers tool. Psychooncology. 2010; 19(2): 125-133.
- 18Curry C, Cossich T, Matthews J, Beresford J, McLachlan S. Uptake of psychosocial referrals in an outpatient cancer setting: improving service accessibility via the referral process. Support Care Cancer. 2002; 10(7): 549-555.
- 19Steginga SK, Campbell A, Ferguson M, et al. Socio-demographic, psychosocial and attitudinal predictors of help seeking after cancer diagnosis. Psychooncology. 2008; 17(10): 997-1005.
- 20van Scheppingen C, Schroevers MJ, Smink A, et al. Does screening for distress efficiently uncover meetable unmet needs in cancer patients? Psychooncology. 2011; 20(6): 655-663.
- 21Shimizu K, Ishibashi Y, Umezawa S, et al. Feasibility and usefulness of the ‘Distress Screening Program in Ambulatory Care’ in clinical oncology practice. Psychooncology. 2010; 19(7): 718-725.
- 22Brebach R, Sharpe L, Costa DS, Rhodes P, Butow P. Psychological intervention targeting distress for cancer patients: a meta-analytic study investigating uptake and adherence. Psychooncology. 2016; 25(8): 882-890.
- 23Dilworth S, Higgins I, Parker V, Kelly B, Turner J. Patient and health professional's perceived barriers to the delivery of psychosocial care to adults with cancer: a systematic review. Psychooncology. 2014; 23(6): 601-612.
- 24Zwahlen D, Tondorf T, Rothschild S, Koller MT, Rochlitz C, Kiss A. Understanding why cancer patients accept or turn down psycho-oncological support: a prospective observational study including patients' and clinicians' perspectives on communication about distress. BMC Cancer. 2017; 17(1): 385.
- 25Schaeffeler N, Pfeiffer K, Ringwald J, et al. Assessing the need for psychooncological support: screening instruments in combination with patients' subjective evaluation may define psychooncological pathways. Psychooncology. 2015; 24(12): 1784-1791.
- 26Mackenzie LJ, Carey M, Sanson-Fisher R, D'Este C, Yoong SL. A cross-sectional study of radiation oncology outpatients' concern about, preferences for, and perceived barriers to discussing anxiety and depression. Psychooncology. 2015; 24(11): 1392-1397.
- 27Mackenzie LJ, Carey ML, Sanson-Fisher RW, D'Este CA, Paul CL, Yoong SL. Agreement between HADS classifications and single-item screening questions for anxiety and depression: a cross-sectional survey of cancer patients. Ann Oncol. 2014; 25(4): 889-895.
- 28Kugaya A, Akechi T, Okuyama T, Okamura H, Uchitomi Y. Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol. 1998; 28(5): 333-338.
- 29Matsudaira T, Igarashi H, Kikuchi H, et al. Factor structure of the Hospital Anxiety and Depression Scale in Japanese psychiatric outpatient and student populations. Health Qual Life Outcomes. 2009; 7(1): 42.
- 30Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale with the Irritability Depression-Anxiety Scale and the Leeds Situational Anxiety Scale manual. In: GL Assessment Ltd: London, 1994.
- 31Takahashi T, Hondo M, Nishimura K, et al. Evaluation of quality of life and psychological response in cancer patients treated with radiotherapy. Radiat Med. 2008; 26(7): 396-401.
- 32Inoguchi H, Shimizu K, Shimoda H, et al. Screening for untreated depression in cancer patients: a Japanese experience. Jpn J Clin Oncol. 2016; 46(11): 993-999.
- 33Arroll B, Goodyear-Smith F, Kerse N, Fishman T, Gunn J. Effect of the addition of a “help” question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study. BMJ. 2005; 331(7521): 884-884.
- 34Baker-Glenn EA, Park B, Granger L, Symonds P, Mitchell AJ. Desire for psychological support in cancer patients with depression or distress: validation of a simple help question. Psychooncology. 2011; 20(5): 525-531.
- 35Merckaert I, Libert Y, Lieutenant F, et al. Desire for formal psychological support among caregivers of patients with cancer: prevalence and implications for screening their needs. Psychooncology. 2013; 22(6): 1389-1395.
- 36Salander P. Does advocating screening for distress in cancer rest more on ideology than on science? Patient Educ Couns. 2017; 100(5): 858-860.
- 37Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol. 2007; 25(29): 4670-4678.
- 38Keller M, Sommerfeldt S, Fischer C, et al. Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol. 2004; 15(8): 1243-1249.
- 39Singer S, Brown A, Einenkel J, et al. Identifying tumor patients' depression. Support Care Cancer. 2011; 19(11): 1697-1703.
- 40Kawase E, Karasawa K, Shimotsu S, et al. Evaluation of a one-question interview for depression in a radiation oncology department in Japan. Gen Hosp Psychiatry. 2006; 28(4): 321-322.
Citing Literature
